FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Research compound · compound · checked 2026-10-09
VIP (Vasoactive Intestinal Peptide)
VIP (Vasoactive Intestinal Peptide) is listed here as a compound. Endogenous signaling peptide; aviptadil is a synthetic VIP studied in respiratory failure. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use VIP (Vasoactive Intestinal Peptide) or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
- FDA product
- not established
- Compounding
- not established
- Research
- investigational
- Sport
- unknown
What is VIP (Vasoactive Intestinal Peptide)?
Other names in the library: aviptadil, vasoactive intestinal peptide, VIP (10MG), VIP — 5mg / Non-Lyophilized, VIP — 5mg / Premium, VIP Spray — 5mg / Non-Lyophilized, VIP Spray — 5mg / Premium, VIP. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 5 mg, 10 mg. A seller title is a listing. It does not prove the vial matches a paper.
Endogenous signaling peptide; aviptadil is a synthetic VIP studied in respiratory failure.
Regulatory status, dated 2026-10-09
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
investigational. 196 hospitalized patients with critical COVID-19 respiratory failure.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
What the cited papers actually measured
We mark the cited papers as B for 196 hospitalized patients with critical COVID-19 respiratory failure. and The prespecified primary outcome did not reach statistical significance.. Selected secondary findings cannot turn a negative primary endpoint into proven efficacy. The IV trial does not establish nasal-spray wellness effects. The prespecified primary outcome did not reach statistical significance. Selected secondary findings cannot turn a negative primary endpoint into proven efficacy. The IV trial does not establish nasal-spray wellness effects. Risks on the record: Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
We mark the cited papers as B. That is our label for how strong those papers are. It does not say the compound works.
human-trial
The prespecified primary outcome did not reach statistical significance.
196 hospitalized patients with critical COVID-19 respiratory failure. Selected secondary findings cannot turn a negative primary endpoint into proven efficacy. The IV trial does not establish nasal-spray wellness effects.
How long it lasts, how you store it, listed sizes
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
U-100 math for listed VIP (Vasoactive Intestinal Peptide) sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 5 mg | 50 | 25 | 16.7 |
| 10 mg | 100 | 50 | 33.3 |
Risks and mix-ups already on the record
- Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
- No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
- No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
Sources
- VIP primary study · PMID 36044317 · checked 2026-10-09
Questions people ask
Is VIP (Vasoactive Intestinal Peptide) FDA-approved?
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Does PepBear pick an amount of VIP (Vasoactive Intestinal Peptide)?
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Related cards
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.